Cytisinicline Heads Toward FDA Decision as Long-Term Safety Data Backs First New Smoking Cessation Drug in Two Decades
Fresh 52-week safety data presented at ATS 2026 reinforce cytisinicline's profile ahead of a June 20 FDA decision that could bring the first new smoking cessation drug to US patients since 2006.
7 min read8 sources